Results of Treatment of Ulcerative Colitis with Salicylazosulfapyridine

Document Type

Article

Publication Date

1-1-1952

Publication Title

Gastroenterology

ISSN

00165085

Abstract

During the past 2 ½ years 52 patients with chronic ulcerative colitis were treated with oral salicylazosulfapyridine. Ten or 18% of patients revealed an intolerance to the drug and were unable to ingest it due to toxic side-reactions. Twelve or 24% of patients showed no significant therapeutic response to the drug. Thirty or 58% of the series showed significant improvement following treatment without curing the disease. Salicylazosulfapyridine may be a useful drug in the treatment of chronic ulcerative colitis when used carefully and with the realization of its limitations. Experience with this drug suggests further studies for a better tolerated © 1952, All rights reserved.

Volume

21

Issue

1

First Page

133

Last Page

138

DOI

10.1016/S0016-5085(52)80128-3

PubMed ID

14926821

Link to Full Text

Share

COinS